http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62164693-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d01a44763ca6b93334e8a729d66cfb72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10
filingDate 1986-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_091161c4789de22f68396ecd659a7dd2
publicationDate 1987-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S62164693-A
titleOfInvention Tripeptide
abstract NEW MATERIAL:A compound shown by formula I (R is group shown by formula II or -Gly-NH 2 ). n EXAMPLE: A compound shown by formula III. n USE: An analgesic, stronger than morphine hydrochloride, etc., showing prolonged analgesic activity, having low toxicity and low dependence and showing im proved activity even by oral administration. n PREPARATION: For example, Boc-Phe-ONSu (Boc is t-butoxycarbonyl; ONSu is N-hydroxysuccinimide ester) is condensed with H-βAla-OBzl.Tos (Tos is tosyl) in the presence of triethylamine, etc., in a solvent such as DMF, etc., to give a compound shown by formula IV, which is treated with a solution of hydrochloric acid-dioxane to remove a protecting group Boc. Then, the com pound is successively condensed with Boc-D-Arg(NO 2 )-OH and Boc-Tyr-OH by the same method to give a compound shown by formula V, which is decom posed with an acid such as trifluoroacetic acid, etc., in the presence of a cationic scavenger such as anisole, etc., and deprotected to give a compound as exempli fied. n COPYRIGHT: (C)1987,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0113938-A1
priorityDate 1986-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7021876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453865105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227552018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12209349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453706522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20443148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422365567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426130730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425413332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117439

Total number of triples: 41.